The United Arab Emirates is advancing a federal strategy to implement compulsory early cancer detection screenings across the nation, connecting participation directly to health insurance requirements. Health Minister Ahmed Al Sayegh announced this significant healthcare policy shift during a Federal National Council session on Wednesday, January 7, 2026.
Minister Al Sayegh emphasized that early cancer detection represents one of the most effective approaches for enhancing survival rates while simultaneously reducing both the economic burden and long-term health consequences of cancer. This initiative emerges amid increasing global cancer incidence rates.
Abu Dhabi’s pioneering ‘Ifhas’ program serves as the model for this nationwide expansion. This comprehensive screening framework currently covers citizens from age 18, conducting evaluations every two to three years—or more frequently based on individual medical risk profiles. The program targets several prevalent cancers including breast, colorectal, cervical, and lung cancer, alongside preventive testing for chronic conditions such as diabetes, cardiovascular disease, and hypertension.
The federal expansion involves standardizing preventive screening protocols across all emirates. The ‘Itmi’nan’ program, operated by Emirates Health Services, provides periodic screening for non-communicable diseases and certain cancers, and is being integrated into standard healthcare pathways with plans for enhanced scope and coverage.
The UAE is increasingly employing cutting-edge diagnostic technologies including liquid biopsies, genetic testing, advanced laboratory diagnostics, and artificial intelligence-supported medical imaging. These technologies enable more accurate and rapid diagnoses, facilitating earlier clinical interventions and allowing healthcare providers to implement risk-based, personalized screening protocols rather than relying exclusively on age-based testing models.
Looking toward the future, Minister Al Sayegh highlighted the National Genome Programme’s role in advancing preventive healthcare. This initiative will help medical teams identify genetic risk factors that might necessitate early monitoring or intervention, reflecting a broader national shift toward evidence-based, proactive healthcare supported by scientific and technological innovation.
FNC member Naama Al Sharhan endorsed these efforts while emphasizing the need for stronger participation rates, particularly for cancers with high mortality rates. She noted that early detection not only improves treatment outcomes but also reduces the emotional and financial strain on families.
The Ministry of Health and Prevention continues to refine its preventive health strategy in coordination with federal and local partners, aiming to protect public health and ensure the healthcare system’s long-term sustainability in alignment with international best practices.